-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Editas Medicine, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
- Editas Medicine, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$71.9M, a 63.1% decline year-over-year.
- Editas Medicine, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$213M, a 1.39% increase year-over-year.
- Editas Medicine, Inc. annual Operating Income (Loss) for 2023 was -$169M, a 25.1% increase from 2022.
- Editas Medicine, Inc. annual Operating Income (Loss) for 2022 was -$226M, a 17% decline from 2021.
- Editas Medicine, Inc. annual Operating Income (Loss) for 2021 was -$193M, a 43.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)